Phenotypic variations and switches in HIV isolated from the blood and the gastrointestinal tissues of patients with HIV-1 infection

Journal of Medical Virology

Volumn 52, Issue 1, 1997, Pages 31-34

  Al Mulla, W ^a,b   Church, D ^b   Gill, M J ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

gastrointestinal biopsies; HIV enteropathy; reversion; syncytium inducing (SI) variant

Indexed keywords

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; VIRUS EXPRESSION; VIRUS REPLICATION;

BIOPSY; DIDANOSINE; DIGESTIVE SYSTEM; FEMALE; GIANT CELLS; HIV; HIV ENTEROPATHY; HIV INFECTIONS; HUMANS; MALE; MUTATION; PHENOTYPE; PROSPECTIVE STUDIES; STAVUDINE; VIRAL LOAD; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030943135     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199705)52:1<31::AID-JMV6>3.0.CO;2-S     Document Type: Article

References (14)

1. Bozzette SA, McCutchan AM, Spector SA, Wright B. and Richman DR (1993): A cross sectional comparison of persons with syncytium and non-syncytium-inducing human immunodeficiency virus. Journal of Infectious Diseases 168:1374-1380.
2. Coffin JM (1995): HIV population dynamics in vivo: Implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
3. Delforge ML, Liesnard C, Debasieux L, Tchetcheroff M, Farber CM, and Vooren JP (1995): In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didauosine. AIDS 9:89-90.
4. Gelb A and Miller S (1987): AIDS and Gastroenterology. American Journal of Gastroenterology 81:619-622.
5. Gill MJ, Sutherland LR, Church DL, and The University of Calgary Gastrointestinal/HIV Study Group (1992): Gastrointestinal tissue cultures for HIV in HIV-infected patients. AIDS 6:553-556.
6. Karlson A, Parsmyr K, Sandstrom E, Fenyo EM, and Albert J (1994): MT-2 cell tropism as prognostic markers for disease progression in human immunodeficiency virus type 1 infection. Journal of Clinical Microbiology 32:364-370.
7. Koot M, Keet I, Vos AH, de Goede RE, Roos M, Coutinho RA, Miedema F, Schellekens P, Tersmette M (1993): Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Annals of Internal Medicine 118:681-688.
8. Koyanagi Y, Miles S, Mitsuyasu RT, Merril JE, Vinters HV, and Chen IS (1987): Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
9. McGavin CH, Land SA, Sebire KL, Hooker DJ, Gurusinghe AD, and Birch CJ (1996): Syncytium-inducing phenotype and zidovudine susceptibility of HIV-1 isolated from post-mortem tissue. AIDS 10:47-53.
10. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W and Levy JA (1988): Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1:259-262.
11. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993): HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of the disease. Nature 362:355-358.
12. Tersmette M, DeGoede RE, Al BJ (1988): Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Journal of Virology 62:2026-2032.
13. Ullrich R, Zeitz M, Heise W, L'age M, Hoffken G, and Reiken E (1989): Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): Evidence for HIV-induced enteropathy. Annals of Internal Medicine 111:15-21.
14. Zheng NN, McQueen PW, Hurren L, Evans LA, Law MG, Forde S, Barker S, Cooper DA, Delaney SF (1996): Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with Didanosine. The Journal of Infectious Diseases 173: 1092-1096.